Janux Therapeutics, Inc. · NASDAQ:JANX
Campbell David Alan exercised options for 7,000 Janux Therapeutics, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Campbell David Alan (Director, President and CEO) exercised options for 7,000 Janux Therapeutics, Inc. shares at US$4.21 for US$29,470, leaving 388,582 shares. Filed Jul 10, 2026 (Form 4).
- Options exercised
- 7,000 shares
- Price
- US$4.21
- Value
- US$29,470
- Holding after
- 388,582 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Option exercise | 7,000 | US$4.21 | 388,582 | Direct |
Source
Related
- Janux Therapeutics, Inc.
- Campbell David Alan
- Janux Therapeutics, Inc. shareholders
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 12, 2026
- Form 4 · Simson Jake · Jun 12, 2026